RT Journal Article
SR Electronic
T1 High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP OA4950
DO 10.1183/13993003.congress-2019.OA4950
VO 54
IS suppl 63
A1 Chau, Trisha
A1 Blade, Kelvin
A1 Da Silva, Juas
A1 Ghaffari, Abdi
A1 Zelazny, Adrian
A1 Olivier, Kenneth
YR 2019
UL https://publications.ersnet.org//content/54/suppl_63/OA4950.abstract
AB Mycobacterium abscessus (M. abscessus) is an emerging multi-drug resistant non-tuberculous mycobacterium (NTM) with increasing prevalence in patients with underlying lung disease. We have demonstrated that high-dose nitric oxide (NO) shows potent antibacterial activity against M. abscessus in vitro. Arikayce® (amikacin liposome inhalation) was recently approved by FDA for the treatment of refractory Mycobacterium avium complex lung infection. Clofazimine, used in treatment of leprosy and tuberculosis, has been increasingly utilized in the treatment of M. abscessus lung infection. In this study, we investigated the synergistic effect of high-dose NO combined with amikacin and clofazimine against M. abscessus. We have used a NO Exposure Chamber to test the susceptibility of three M. abscessus clinical strains (MAB-062600, MAB-030804, and MAB-010708) and ATCC 19977 to NO and its combination with clofazimine and amikacin. Disc Diffusion or E-test methods was used to determine the minimum inhibitory concentrations (MICs) for each strain followed by Agar Dilution method to determine synergistic effects. Treatment with 250ppm NO alone for 10hr demonstrated a 5- to 6-log reductions in M. abscessus clinical strains and ATCC 19977. Preliminary results indicate that NO in combination with clofazimine (2X MIC) results in an additional 1-log reduction in MAB-062600 strain compared to NO and CLO alone. Tests on the effects of clofazimine and amikacin in combination with 250ppm NO in remaining M. abscessus strains are ongoing. Our findings suggests that 250ppm NO is highly efficacious against M. abscessus and combination with clofazimine may further improve its activity.FootnotesCite this article as: European Respiratory Journal 2019; 54: Suppl. 63, OA4950.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).